Pub Date : 2025-09-25eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025021
Arosh S Perera Molligoda Arachchige
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive degeneration of the upper and lower motor neurons, which leads to muscle atrophy, spasticity, and ultimately respiratory failure. The etiology of ALS remains unclear, though a combination of genetic and environmental factors is suspected. Advances in understanding ALS pathophysiology, including the role of RNA metabolism, mitochondrial dysfunction, and glutamate toxicity, have paved the way for new research directions. While Riluzole offers limited survival benefits, there is no cure, and treatment remains mostly supportive. This article summarizes the current understanding of ALS in terms of its pathophysiology, epidemiology, risk factors, clinical presentation, and treatment strategies.
{"title":"Rethinking ALS: Current understanding and emerging therapeutic strategies.","authors":"Arosh S Perera Molligoda Arachchige","doi":"10.3934/Neuroscience.2025021","DOIUrl":"10.3934/Neuroscience.2025021","url":null,"abstract":"<p><p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive degeneration of the upper and lower motor neurons, which leads to muscle atrophy, spasticity, and ultimately respiratory failure. The etiology of ALS remains unclear, though a combination of genetic and environmental factors is suspected. Advances in understanding ALS pathophysiology, including the role of RNA metabolism, mitochondrial dysfunction, and glutamate toxicity, have paved the way for new research directions. While Riluzole offers limited survival benefits, there is no cure, and treatment remains mostly supportive. This article summarizes the current understanding of ALS in terms of its pathophysiology, epidemiology, risk factors, clinical presentation, and treatment strategies.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"391-405"},"PeriodicalIF":2.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-25eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025022
Kiruthika Selvakumar, Lee Wan Fei, Deepak Thazhakkattu Vasu, Nandakumari P Velayan Sabapathy
Background and objective: Headache disorders are ranked among the top 10 causes of disability worldwide and are notably prevalent within university student populations. This study aimed to (a) assess the prevalence of headaches and their impact among university students, (b) examine the correlation between headaches and dynamic balance, and (c) investigate the correlation between headaches and levels of physical activity.
Methods: The cross-sectional study was conducted at Universiti Tunku Abdul Rahman and involved 471 participants by using convenience sampling. A digital screening questionnaire was used to obtain demographic data and screen the participants. The Headache Impact Test (HIT-6) and the self-administered short International Physical Activity Questionnaire (IPAQ) Long Last 7 Days were conducted by eligible participants. Timed Up and Go (TUG) and Timed Up and Go Dual Task (TUG-DT; Cognitive and Manual) were assessed to measure dynamic balance.
Results: A 96.9% response rate was obtained in the study. The prevalence of headaches among university students was 44% (n = 208). Spearman correlation analysis indicated very weak to weak correlations that are not statistically significant between headache severity and physical activity levels (r = 0.064, p > 0.05), or with single-task dynamic balance (r = 0.118, p > 0.05) and manual dual-task balance (r = 0.183, p > 0.05). However, a significant positive correlation was observed between headache severity and cognitive dual-task balance performance (r = 0.292, p < 0.05), indicating that greater headache impact is associated with poorer balance under cognitive dual-task conditions.
Conclusions: Headache prevalence among university students was 44%, higher in females and younger individuals. While headache severity showed no significant correlation with physical activity or most dynamic balance measures, it was significantly associated with impaired balance under cognitive dual-task conditions, indicating a potential impact on motor-cognitive integration.
背景和目的:头痛疾病是世界范围内十大致残原因之一,在大学生群体中尤为普遍。本研究旨在(a)评估头痛的患病率及其在大学生中的影响,(b)检查头痛与动态平衡之间的相关性,(c)调查头痛与身体活动水平之间的相关性。方法:横断面研究在东姑阿卜杜勒拉赫曼大学进行,采用方便抽样法,共纳入471名受试者。使用数字筛选问卷获取人口统计数据并对参与者进行筛选。对符合条件的受试者进行头痛影响测试(HIT-6)和自填短国际身体活动问卷(IPAQ)。评估动态平衡(TUG)和双重任务(TUG- dt;认知和手动)。结果:有效率为96.9%。大学生头痛患病率为44% (n = 208)。Spearman相关分析显示,头痛严重程度与体力活动水平、单任务动态平衡(r = 0.118, p > 0.05)和手动双任务平衡(r = 0.183, p > 0.05)之间存在极弱至弱相关,无统计学意义。然而,头痛严重程度与认知双任务平衡表现之间存在显著正相关(r = 0.292, p < 0.05),表明认知双任务条件下,头痛影响越大,平衡能力越差。结论:大学生头痛患病率为44%,女性和年轻人较高。虽然头痛严重程度与身体活动或大多数动态平衡测量没有显著相关性,但在认知双任务条件下,头痛严重程度与平衡受损显著相关,表明对运动-认知整合有潜在影响。
{"title":"Impact of headache on physical activity levels and dynamic balance among university students.","authors":"Kiruthika Selvakumar, Lee Wan Fei, Deepak Thazhakkattu Vasu, Nandakumari P Velayan Sabapathy","doi":"10.3934/Neuroscience.2025022","DOIUrl":"10.3934/Neuroscience.2025022","url":null,"abstract":"<p><strong>Background and objective: </strong>Headache disorders are ranked among the top 10 causes of disability worldwide and are notably prevalent within university student populations. This study aimed to (a) assess the prevalence of headaches and their impact among university students, (b) examine the correlation between headaches and dynamic balance, and (c) investigate the correlation between headaches and levels of physical activity.</p><p><strong>Methods: </strong>The cross-sectional study was conducted at Universiti Tunku Abdul Rahman and involved 471 participants by using convenience sampling. A digital screening questionnaire was used to obtain demographic data and screen the participants. The Headache Impact Test (HIT-6) and the self-administered short International Physical Activity Questionnaire (IPAQ) Long Last 7 Days were conducted by eligible participants. Timed Up and Go (TUG) and Timed Up and Go Dual Task (TUG-DT; Cognitive and Manual) were assessed to measure dynamic balance.</p><p><strong>Results: </strong>A 96.9% response rate was obtained in the study. The prevalence of headaches among university students was 44% (n = 208). Spearman correlation analysis indicated very weak to weak correlations that are not statistically significant between headache severity and physical activity levels (r = 0.064, p > 0.05), or with single-task dynamic balance (r = 0.118, p > 0.05) and manual dual-task balance (r = 0.183, p > 0.05). However, a significant positive correlation was observed between headache severity and cognitive dual-task balance performance (r = 0.292, p < 0.05), indicating that greater headache impact is associated with poorer balance under cognitive dual-task conditions.</p><p><strong>Conclusions: </strong>Headache prevalence among university students was 44%, higher in females and younger individuals. While headache severity showed no significant correlation with physical activity or most dynamic balance measures, it was significantly associated with impaired balance under cognitive dual-task conditions, indicating a potential impact on motor-cognitive integration.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"406-417"},"PeriodicalIF":2.7,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025020
Taslim Uddin
Neurons are especially vulnerable because of their high metabolic activity and limited ability to repair damaged DNA. Oxidative genotoxic stress (OGS), which arises from the buildup of short-lived, highly reactive molecules called reactive oxygen species (ROS), can damage neuronal DNA and compromise antioxidant defense mechanisms in neurons. OGS induces considerable forms of DNA damage, including genomic instability, DNA strand breaks (single or double), DNA base modifications such as 8-oxoguanine, and epigenetic changes, leading to compromised neuronal functions. Moreover, OGS is a silent player in mitochondrial DNA damage and mitochondrial dysfunction. Therefore, ROS-mediated OGS is pivotal for initiating and advancing several neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinsonism (PD), and Huntington's disease (HD). However, there is a significant gap in deciphering the molecular pathways involved in OGS-mediated development of neurodegenerative diseases. Hence, this study focused on the molecular mechanisms by which OGS causes neurodegeneration, with a focus on the contributions of neuroinflammation, mitochondrial dysfunction, and defective DNA repair pathways. Additionally, new therapeutic approaches, such as mitochondrial-targeted medications, antioxidant therapies, gene editing tools such as CRISPR/Cas9, and biomarkers for the early diagnosis of these oxidative diseases, have been assessed. A thorough comprehension of these processes opens exciting possibilities for focused treatments in neurodegenerative illnesses.
{"title":"Oxidative genomic or genotoxic stress in neurodegeneration: Mechanisms and therapeutic avenues.","authors":"Taslim Uddin","doi":"10.3934/Neuroscience.2025020","DOIUrl":"10.3934/Neuroscience.2025020","url":null,"abstract":"<p><p>Neurons are especially vulnerable because of their high metabolic activity and limited ability to repair damaged DNA. Oxidative genotoxic stress (OGS), which arises from the buildup of short-lived, highly reactive molecules called reactive oxygen species (ROS), can damage neuronal DNA and compromise antioxidant defense mechanisms in neurons. OGS induces considerable forms of DNA damage, including genomic instability, DNA strand breaks (single or double), DNA base modifications such as 8-oxoguanine, and epigenetic changes, leading to compromised neuronal functions. Moreover, OGS is a silent player in mitochondrial DNA damage and mitochondrial dysfunction. Therefore, ROS-mediated OGS is pivotal for initiating and advancing several neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinsonism (PD), and Huntington's disease (HD). However, there is a significant gap in deciphering the molecular pathways involved in OGS-mediated development of neurodegenerative diseases. Hence, this study focused on the molecular mechanisms by which OGS causes neurodegeneration, with a focus on the contributions of neuroinflammation, mitochondrial dysfunction, and defective DNA repair pathways. Additionally, new therapeutic approaches, such as mitochondrial-targeted medications, antioxidant therapies, gene editing tools such as CRISPR/Cas9, and biomarkers for the early diagnosis of these oxidative diseases, have been assessed. A thorough comprehension of these processes opens exciting possibilities for focused treatments in neurodegenerative illnesses.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"369-390"},"PeriodicalIF":2.7,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-21eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025019
Lora J Kasselman, Saba Ahmed, Ariel De Leon, Maryann Johnson, Ankita Srivastava, Apoorva Vashisht, Heather A Renna, Thomas Palaia, Aaron Pinkhasov, Allison B Reiss
Major depressive disorder is one of the most burdensome mental health disorders. Probiotics have been shown to ameliorate depressive symptoms, though the mechanism remains unclear. This study was conducted to investigate whether extracellular vesicles (EVs) extracted from the probiotic beverage water kefir could influence gene and protein expression in human-derived neuroblastoma cells in vitro. EVs were extracted from lab-cultured water kefir and a control solution without water kefir grains by ultracentrifugation. Water kefir vesicles were imaged via electron microscopy. Neuroblastoma, microglia, and neuroblastoma-microglia co-cultures were exposed to water kefir EVs or negative control medium. Uptake of water kefir EVs was identified by microscopy. All conditions were quantified for brain derived neurotrophic factor, fractalkine, and synaptophysin RNA and protein. Data were analyzed using factorial ANOVAs with significance set at 0.05. Water kefir vesicles were taken up by neuroblastoma cells, and incubation in neuroblastoma-microglia co-culture resulted in significantly higher levels of fractalkine protein compared to media-only control (p = 0.029). To our knowledge, this is the first study to identify potential interactions between EVs derived from the probiotic beverage water kefir and human neuronal cells. Further research is needed to fully elucidate the role played by probiotic-derived EVs in human health.
{"title":"Extracellular vesicles from water kefir can interact with human neurons in vitro: a potential explanation for the role of probiotics consumption in mental health.","authors":"Lora J Kasselman, Saba Ahmed, Ariel De Leon, Maryann Johnson, Ankita Srivastava, Apoorva Vashisht, Heather A Renna, Thomas Palaia, Aaron Pinkhasov, Allison B Reiss","doi":"10.3934/Neuroscience.2025019","DOIUrl":"10.3934/Neuroscience.2025019","url":null,"abstract":"<p><p>Major depressive disorder is one of the most burdensome mental health disorders. Probiotics have been shown to ameliorate depressive symptoms, though the mechanism remains unclear. This study was conducted to investigate whether extracellular vesicles (EVs) extracted from the probiotic beverage water kefir could influence gene and protein expression in human-derived neuroblastoma cells in vitro. EVs were extracted from lab-cultured water kefir and a control solution without water kefir grains by ultracentrifugation. Water kefir vesicles were imaged via electron microscopy. Neuroblastoma, microglia, and neuroblastoma-microglia co-cultures were exposed to water kefir EVs or negative control medium. Uptake of water kefir EVs was identified by microscopy. All conditions were quantified for brain derived neurotrophic factor, fractalkine, and synaptophysin RNA and protein. Data were analyzed using factorial ANOVAs with significance set at 0.05. Water kefir vesicles were taken up by neuroblastoma cells, and incubation in neuroblastoma-microglia co-culture resulted in significantly higher levels of fractalkine protein compared to media-only control (p = 0.029). To our knowledge, this is the first study to identify potential interactions between EVs derived from the probiotic beverage water kefir and human neuronal cells. Further research is needed to fully elucidate the role played by probiotic-derived EVs in human health.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"351-368"},"PeriodicalIF":2.7,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-25eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025018
Fiammetta Iannuzzo, Fabrizio Turiaco, Vincenzo Messina, Alessandro Magazzù Minutoli, Maria Catena Silvestri, Maria Rosaria Anna Muscatello, Antonio Bruno
Data suggests that the available therapeutic tools are still insufficient to deal with suicidality. Non-Invasive Brain Stimulation techniques (NIBS) have entered the recognized guidelines for therapies in psychiatry due to the advantages related to safety and tolerability. The purpose of this review and meta-analysis is to assess if and how NIBS techniques are used and could be effective in the treatment of suicidal ideation. The search included the Scopus, Pubmed, and Web of Science databases. The word "suicide" was combined with "NIBS", "transcranial magnetic stimulation" (TMS), "deep TMS" and "transcranial direct current stimulation". Nine studies met the inclusion criteria and were included in the review. High frequency repetitive TMS (rTMS) protocols were associated with a significant reduction in suicidal ideation, with individual studies reporting improvements ranging from 20% to over 35% on scales such as the scale for suicide ideation (SSI) and the Beck scale of suicide ideation (BSI) (p < 0.01; p < 0.01; p < 0.001). The meta-analysis showed that active rTMS significantly reduced suicidal ideation compared to sham control conditions (Z = 16.79, p < 0.0001). Heterogeneity was high (I² = 99%, chi-square = 473.22, df = 3, p < 0.0001). High frequency rTMS protocols appeared most effective; deep TMS (dTMS) showed mixed results, and only one study utilized transcranial direct current stimulation (tDCS). Due to limited data, no meta-analysis was conducted on dTMS or tDCS studies. Although preliminary findings suggest a potential for NIBS techniques to reduce suicidal ideation, the current evidence is limited by the small number of high-quality studies and heterogeneity in the protocols and outcomes. Therefore, conclusions regarding clinical efficacy should be considered tentative.
数据表明,现有的治疗手段仍然不足以应对自杀。非侵入性脑刺激技术(NIBS)由于其安全性和耐受性方面的优势,已进入公认的精神病学治疗指南。本综述和荟萃分析的目的是评估NIBS技术是否和如何用于治疗自杀意念,以及是否有效。搜索包括Scopus, Pubmed和Web of Science数据库。“自杀”一词与“NIBS”、“经颅磁刺激”(TMS)、“深颅磁刺激”和“经颅直流电刺激”结合在一起。9项研究符合纳入标准并被纳入本综述。高频重复TMS (rTMS)方案与自杀意念的显著减少有关,个别研究报告自杀意念量表(SSI)和贝克自杀意念量表(BSI)等量表的改善幅度从20%到35%以上(p < 0.01; p < 0.01; p < 0.001)。meta分析显示,与假对照相比,激活rTMS显著降低自杀意念(Z = 16.79, p < 0.0001)。异质性高(I²= 99%,卡方= 473.22,df = 3, p < 0.0001)。高频rTMS方案最有效;深颅磁刺激(dTMS)的结果好坏不一,只有一项研究使用了经颅直流电刺激(tDCS)。由于资料有限,未对dTMS或tDCS研究进行meta分析。虽然初步发现表明NIBS技术有可能减少自杀意念,但目前的证据受到高质量研究数量少以及方案和结果异质性的限制。因此,关于临床疗效的结论应被视为试探性的。
{"title":"Non-invasive brain stimulation for suicidal ideation: a systematic review and metanalysis of the current literature.","authors":"Fiammetta Iannuzzo, Fabrizio Turiaco, Vincenzo Messina, Alessandro Magazzù Minutoli, Maria Catena Silvestri, Maria Rosaria Anna Muscatello, Antonio Bruno","doi":"10.3934/Neuroscience.2025018","DOIUrl":"10.3934/Neuroscience.2025018","url":null,"abstract":"<p><p>Data suggests that the available therapeutic tools are still insufficient to deal with suicidality. Non-Invasive Brain Stimulation techniques (NIBS) have entered the recognized guidelines for therapies in psychiatry due to the advantages related to safety and tolerability. The purpose of this review and meta-analysis is to assess if and how NIBS techniques are used and could be effective in the treatment of suicidal ideation. The search included the Scopus, Pubmed, and Web of Science databases. The word \"suicide\" was combined with \"NIBS\", \"transcranial magnetic stimulation\" (TMS), \"deep TMS\" and \"transcranial direct current stimulation\". Nine studies met the inclusion criteria and were included in the review. High frequency repetitive TMS (rTMS) protocols were associated with a significant reduction in suicidal ideation, with individual studies reporting improvements ranging from 20% to over 35% on scales such as the scale for suicide ideation (SSI) and the Beck scale of suicide ideation (BSI) (p < 0.01; p < 0.01; p < 0.001). The meta-analysis showed that active rTMS significantly reduced suicidal ideation compared to sham control conditions (Z = 16.79, p < 0.0001). Heterogeneity was high (I² = 99%, chi-square = 473.22, df = 3, p < 0.0001). High frequency rTMS protocols appeared most effective; deep TMS (dTMS) showed mixed results, and only one study utilized transcranial direct current stimulation (tDCS). Due to limited data, no meta-analysis was conducted on dTMS or tDCS studies. Although preliminary findings suggest a potential for NIBS techniques to reduce suicidal ideation, the current evidence is limited by the small number of high-quality studies and heterogeneity in the protocols and outcomes. Therefore, conclusions regarding clinical efficacy should be considered tentative.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"332-350"},"PeriodicalIF":2.7,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-21eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025017
Hadi Mohammadi Nia Samakosh, Maedeh Maktoubian, Seyyed Pedram Rouhani Doost, Rafael Oliveira, Georgian Badicu, Sameer Badri Al-Mhanna, Mahdieh Hassanzadeh, Peyman Amadekhiar, Reza Rezaeain Vaskasi
Dynamic knee valgus (DKV) is a prevalent risk factor for anterior cruciate ligament (ACL) injuries in soccer players, particularly during noncontact mechanisms. Transcranial direct-current stimulation (tDCS) and core stability exercises have shown promise in enhancing motor control and biomechanical alignment, but their combined effects on DKV remain unexplored. This study aimed to evaluate the efficacy of active versus sham tDCS combined with core stability exercises on knee kinematic alignment and lower limb performance in young male soccer players with DKV. In this double-blind, randomized controlled trial, 42 male soccer players (aged 18-25 years) with DKV were randomly assigned to either an active tDCS group (n = 21) or a sham tDCS group (n = 21). Both groups underwent 8 weeks of core stability exercises (3 sessions/week, 30 minutes/session) preceded by 15 minutes of active (2 mA) or sham tDCS targeting the primary motor cortex (M1). The primary outcome was the frontal plane projection angle (FPPA) during a single-leg landing task, measured using 2D video analysis. Secondary outcomes included vertical jump height and 8-hop test time. Outcomes were assessed at baseline and post-intervention. A 2 × 2 mixed-model ANOVA with Bonferroni-corrected post hoc tests was used for statistical analysis via SPSS27. The active tDCS group showed significantly greater improvements in FPPA (+5.65% vs. +2.26%, p < 0.001, ηp² = 0.82), vertical jump height (+25.30% vs. +10.45%, p < 0.001, ηp² = 0.75), and 8-hop test time (-21.05% vs. -14.27%, p < 0.001, ηp² = 0.68) compared to the sham group. Both groups improved from baseline, but the active tDCS group exhibited larger effect sizes across all outcomes. Active tDCS combined with core stability exercises significantly enhanced knee kinematic alignment and lower limb performance in soccer players with DKV compared to sham tDCS. These findings suggest that neuromodulation, when paired with targeted exercise, is a promising strategy for injury prevention and performance enhancement in athletes. Further research is needed to explore long-term effects and applicability to diverse populations.
{"title":"Active and sham transcranial direct-current stimulation (tDCS) plus core stability on the knee kinematic and performance of the lower limb of the soccer players with dynamic knee valgus; two armed randomized clinical trial.","authors":"Hadi Mohammadi Nia Samakosh, Maedeh Maktoubian, Seyyed Pedram Rouhani Doost, Rafael Oliveira, Georgian Badicu, Sameer Badri Al-Mhanna, Mahdieh Hassanzadeh, Peyman Amadekhiar, Reza Rezaeain Vaskasi","doi":"10.3934/Neuroscience.2025017","DOIUrl":"10.3934/Neuroscience.2025017","url":null,"abstract":"<p><p>Dynamic knee valgus (DKV) is a prevalent risk factor for anterior cruciate ligament (ACL) injuries in soccer players, particularly during noncontact mechanisms. Transcranial direct-current stimulation (tDCS) and core stability exercises have shown promise in enhancing motor control and biomechanical alignment, but their combined effects on DKV remain unexplored. This study aimed to evaluate the efficacy of active versus sham tDCS combined with core stability exercises on knee kinematic alignment and lower limb performance in young male soccer players with DKV. In this double-blind, randomized controlled trial, 42 male soccer players (aged 18-25 years) with DKV were randomly assigned to either an active tDCS group (n = 21) or a sham tDCS group (n = 21). Both groups underwent 8 weeks of core stability exercises (3 sessions/week, 30 minutes/session) preceded by 15 minutes of active (2 mA) or sham tDCS targeting the primary motor cortex (M1). The primary outcome was the frontal plane projection angle (FPPA) during a single-leg landing task, measured using 2D video analysis. Secondary outcomes included vertical jump height and 8-hop test time. Outcomes were assessed at baseline and post-intervention. A 2 × 2 mixed-model ANOVA with Bonferroni-corrected post hoc tests was used for statistical analysis via SPSS<sub>27</sub>. The active tDCS group showed significantly greater improvements in FPPA (+5.65% vs. +2.26%, p < 0.001, <i>η</i>p² = 0.82), vertical jump height (+25.30% vs. +10.45%, p < 0.001, <i>η</i>p² = 0.75), and 8-hop test time (-21.05% vs. -14.27%, p < 0.001, <i>η</i>p² = 0.68) compared to the sham group. Both groups improved from baseline, but the active tDCS group exhibited larger effect sizes across all outcomes. Active tDCS combined with core stability exercises significantly enhanced knee kinematic alignment and lower limb performance in soccer players with DKV compared to sham tDCS. These findings suggest that neuromodulation, when paired with targeted exercise, is a promising strategy for injury prevention and performance enhancement in athletes. Further research is needed to explore long-term effects and applicability to diverse populations.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 3","pages":"312-331"},"PeriodicalIF":2.7,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12521934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145306862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic disorder characterized by progressive muscle weakness, primarily affecting the facial, shoulder, and upper arm muscles. In this literature review, we examined the available treatments for FSHD, covering established methods and experimental approaches. We began with an overview of pharmacological treatments, emphasizing the importance of physical therapy and rehabilitation in maintaining muscle strength, improving mobility, preventing contractures, and respiratory therapy for severe cases. We also explored exercise interventions, addressing the debate surrounding exercise in FSHD patients, and highlight the possible benefits of aerobic and strength training, as well as ongoing research into safe exercise protocols. Additionally, the use of assistive devices and orthotics, such as braces and mobility aids, is discussed, along with surgical interventions like scapular fixation surgery and corrective procedures for foot drop. Emerging therapeutic strategies, including gene therapy focusing on DUX4 silencing and CRISPR-Cas9 technology, were evaluated. The potential of antisense oligonucleotides and myostatin inhibitors was reviewed, along with the challenges and ethical considerations associated with cell-based therapies. We aimed to inform researchers and advance treatment strategies for FSHD patients.
{"title":"Current landscape for the management of facioscapulohumeral muscular dystrophy and emerging treatment modalities: A literature review.","authors":"Ubaid Ansari, Dawnica Nadora, Lauren Ong, Romteen Sedighi, Ethan Tabaie, Zaid Ansari, Meraj Alam, Burhaan Syed, Noorhan Amani, Sarah Preiss-Farzanegan","doi":"10.3934/Neuroscience.2025016","DOIUrl":"10.3934/Neuroscience.2025016","url":null,"abstract":"<p><p>Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic disorder characterized by progressive muscle weakness, primarily affecting the facial, shoulder, and upper arm muscles. In this literature review, we examined the available treatments for FSHD, covering established methods and experimental approaches. We began with an overview of pharmacological treatments, emphasizing the importance of physical therapy and rehabilitation in maintaining muscle strength, improving mobility, preventing contractures, and respiratory therapy for severe cases. We also explored exercise interventions, addressing the debate surrounding exercise in FSHD patients, and highlight the possible benefits of aerobic and strength training, as well as ongoing research into safe exercise protocols. Additionally, the use of assistive devices and orthotics, such as braces and mobility aids, is discussed, along with surgical interventions like scapular fixation surgery and corrective procedures for foot drop. Emerging therapeutic strategies, including gene therapy focusing on DUX4 silencing and CRISPR-Cas9 technology, were evaluated. The potential of antisense oligonucleotides and myostatin inhibitors was reviewed, along with the challenges and ethical considerations associated with cell-based therapies. We aimed to inform researchers and advance treatment strategies for FSHD patients.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 2","pages":"291-311"},"PeriodicalIF":2.7,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-24eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025015
Rosa Giacca, Miriana Conte, Alessandro d'Ambrosio, Alvino Bisecco, Renato Docimo, Mario Risi, Manuela Altieri, Riccardo Borgo, Rosario Domenico Melisi, Vittorio Gentile, Antonio Gallo
The calcium-dependent enzyme Transglutaminase 2 (TG2) (E.C. 2.3.2.13), which can promote post-translational modifications of proteins, is involved in several physiological processes, including development, neuronal cell death, and differentiation, as well as synaptic plasticity and transmission in the central nervous system (CNS). Several studies highlight the potential role of the TG2/NF-κB activation pathway in neurodegenerative diseases, including Multiple Sclerosis (MS), and the neuroinflammation that is associated with these conditions. The cross-linking activity of TG2, facilitating the formation of isopeptide bonds between glutamine and lysine residues, appears to be involved in forming protein aggregate deposits in these pathological conditions. Specifically, in the chronic neuroinflammation of MS, TG2 seems to play a central role in the fibrotic process of the lesion. Several potential biomarkers have been investigated for the prognosis and monitoring of MS, but no researchers have explored the presence of potential inflammatory signals in peripheral blood mononuclear cells (PBMCs) during the presymptomatic stage of MS, known as Radiologically Isolated Syndrome (RIS), on account of the lack of information regarding its pathological aspects. Since researchers have demonstrated a correlation between TG2 mRNA levels in PBMCs and the clinical and radiological progression of MS, we aimed to evaluate the expression levels of TG2 in RIS patients, comparing them with those in relapsing-remitting MS (RRMS) patients and healthy controls (HCs) using real-time PCR analysis. Preliminary data showed that RIS patients exhibit lower TG2 mRNA expression levels compared to RRMS patients, while no difference in TG2 mRNA expression being observed between RIS patients and HCs. This suggests that RIS patients exhibit a lower neuroinflammation grade than RRMS patients and that TG2 may represent a potential biochemical marker for assessing neuroinflammation associated with this disease. Future investigations may include longitudinal assessments of the potential role of TG2 mRNA blood levels in predicting or monitoring the progression from RIS to MS.
{"title":"Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study.","authors":"Rosa Giacca, Miriana Conte, Alessandro d'Ambrosio, Alvino Bisecco, Renato Docimo, Mario Risi, Manuela Altieri, Riccardo Borgo, Rosario Domenico Melisi, Vittorio Gentile, Antonio Gallo","doi":"10.3934/Neuroscience.2025015","DOIUrl":"10.3934/Neuroscience.2025015","url":null,"abstract":"<p><p>The calcium-dependent enzyme Transglutaminase 2 (TG2) (E.C. 2.3.2.13), which can promote post-translational modifications of proteins, is involved in several physiological processes, including development, neuronal cell death, and differentiation, as well as synaptic plasticity and transmission in the central nervous system (CNS). Several studies highlight the potential role of the TG2/NF-κB activation pathway in neurodegenerative diseases, including Multiple Sclerosis (MS), and the neuroinflammation that is associated with these conditions. The cross-linking activity of TG2, facilitating the formation of isopeptide bonds between glutamine and lysine residues, appears to be involved in forming protein aggregate deposits in these pathological conditions. Specifically, in the chronic neuroinflammation of MS, TG2 seems to play a central role in the fibrotic process of the lesion. Several potential biomarkers have been investigated for the prognosis and monitoring of MS, but no researchers have explored the presence of potential inflammatory signals in peripheral blood mononuclear cells (PBMCs) during the presymptomatic stage of MS, known as Radiologically Isolated Syndrome (RIS), on account of the lack of information regarding its pathological aspects. Since researchers have demonstrated a correlation between TG2 mRNA levels in PBMCs and the clinical and radiological progression of MS, we aimed to evaluate the expression levels of TG2 in RIS patients, comparing them with those in relapsing-remitting MS (RRMS) patients and healthy controls (HCs) using real-time PCR analysis. Preliminary data showed that RIS patients exhibit lower TG2 mRNA expression levels compared to RRMS patients, while no difference in TG2 mRNA expression being observed between RIS patients and HCs. This suggests that RIS patients exhibit a lower neuroinflammation grade than RRMS patients and that TG2 may represent a potential biochemical marker for assessing neuroinflammation associated with this disease. Future investigations may include longitudinal assessments of the potential role of TG2 mRNA blood levels in predicting or monitoring the progression from RIS to MS.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 2","pages":"284-290"},"PeriodicalIF":2.7,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-23eCollection Date: 2025-01-01DOI: 10.3934/Neuroscience.2025014
Kyung Hee Kim
Although dopamine therapy is known to enhance creativity in some artists with Parkinson's disease (PD), similar creative changes have been observed in individuals with other neurological conditions, even without such treatment. This suggests that broader neurological and psychological factors beyond dopamine alone may influence creativity in PD. In this paper, I examined these influences through the lens of the 7 Muses of the Neuro-Creative Cycle: independence, curiosity, playfulness, confidence, openness, interdependence, and passion. Originally developed to support creativity in healthy individuals, the 7 Muses framework aligns closely with the structural and functional brain changes, as well as psychological shifts, commonly seen in PD. These changes may unlock latent creative potential, enabling PD artists to express themselves more authentically. By promoting a dynamic balance between top-down (goal-directed) and bottom-up (emotion-driven) processing across the creative cycle, preparation, imagination, and verification, PD-related changes may help reduce self-censorship, foster originality, and support the creation of meaningful, valuable work. Ultimately, beyond the effects of dopamine, some PD patients may awaken their dormant muses by following their intrinsic drives, listening more to their heart than their head.
{"title":"The 7 Muses of Neuro-Creative Cycle: How some patients with Parkinson's disease can unleash latent creativity.","authors":"Kyung Hee Kim","doi":"10.3934/Neuroscience.2025014","DOIUrl":"10.3934/Neuroscience.2025014","url":null,"abstract":"<p><p>Although dopamine therapy is known to enhance creativity in some artists with Parkinson's disease (PD), similar creative changes have been observed in individuals with other neurological conditions, even without such treatment. This suggests that broader neurological and psychological factors beyond dopamine alone may influence creativity in PD. In this paper, I examined these influences through the lens of the <i>7 Muses of the Neuro-Creative Cycle</i>: independence, curiosity, playfulness, confidence, openness, interdependence, and passion. Originally developed to support creativity in healthy individuals, the 7 Muses framework aligns closely with the structural and functional brain changes, as well as psychological shifts, commonly seen in PD. These changes may unlock latent creative potential, enabling PD artists to express themselves more authentically. By promoting a dynamic balance between top-down (goal-directed) and bottom-up (emotion-driven) processing across the creative cycle, preparation, imagination, and verification, PD-related changes may help reduce self-censorship, foster originality, and support the creation of meaningful, valuable work. Ultimately, beyond the effects of dopamine, some PD patients may awaken their dormant muses by following their intrinsic drives, listening more to their heart than their head.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 2","pages":"250-283"},"PeriodicalIF":2.7,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287648/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
COVID-19 vaccines have been effective in providing strong immunity within a relatively short time frame, significantly reducing both the severity of the disease and associated mortality. However, post-vaccination complications, particularly neurological disorders, have been reported. Among the more frequently documented neurological complications are acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), transverse myelitis (TM), optic neuritis (ON), Bell's palsy (BP), and Guillain-Barré syndrome (GBS). The precise role of COVID-19 vaccines in triggering the onset or relapse of these conditions remains uncertain. Immunological processes involving cytokines, chemokines, antibodies, and immune cells are believed to contribute to the pathogenesis of these neurological side effects. This review examines the immune responses triggered by COVID-19 vaccines and their potential role in the development of such complications. Despite reports of neurological side effects, these cases remain rare, and the overall benefits of vaccination in curbing the pandemic and preventing severe illness far exceed the risks. It is vital to sustain the progress of global vaccination efforts while continuously evaluating the risk-benefit ratio, particularly for individuals with underlying conditions. Ongoing research and surveillance are crucial for creating safer vaccines and identifying individuals who may be more susceptible to adverse reactions, ensuring broader protection against COVID-19.
{"title":"COVID-19 vaccines and neurological disorders: A narrative review of immune responses and adverse reactions.","authors":"Mehran Joodaki, Farhad Seif, Azadeh Afzalnia, Nikoo Emtiazi, Mona Merati Shirazi, Behnaz Ashtari, Seyed Mohamad Hosseinian, Nasrin Hosseini","doi":"10.3934/Neuroscience.2025013","DOIUrl":"10.3934/Neuroscience.2025013","url":null,"abstract":"<p><p>COVID-19 vaccines have been effective in providing strong immunity within a relatively short time frame, significantly reducing both the severity of the disease and associated mortality. However, post-vaccination complications, particularly neurological disorders, have been reported. Among the more frequently documented neurological complications are acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), transverse myelitis (TM), optic neuritis (ON), Bell's palsy (BP), and Guillain-Barré syndrome (GBS). The precise role of COVID-19 vaccines in triggering the onset or relapse of these conditions remains uncertain. Immunological processes involving cytokines, chemokines, antibodies, and immune cells are believed to contribute to the pathogenesis of these neurological side effects. This review examines the immune responses triggered by COVID-19 vaccines and their potential role in the development of such complications. Despite reports of neurological side effects, these cases remain rare, and the overall benefits of vaccination in curbing the pandemic and preventing severe illness far exceed the risks. It is vital to sustain the progress of global vaccination efforts while continuously evaluating the risk-benefit ratio, particularly for individuals with underlying conditions. Ongoing research and surveillance are crucial for creating safer vaccines and identifying individuals who may be more susceptible to adverse reactions, ensuring broader protection against COVID-19.</p>","PeriodicalId":7732,"journal":{"name":"AIMS Neuroscience","volume":"12 2","pages":"222-249"},"PeriodicalIF":2.7,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}